Skip to content
healthcare.dev

Eohilia

NDC 64764-105, Budesonide, suspension, from TAKEDA PHARMACEUTICALS AMERICA, INC..

Product NDC
64764-105
Status
Listed
Labeler
TAKEDA PHARMACEUTICALS AMERICA, INC.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213976
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64764-105 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUDESONIDE2 mg/10mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
64764-105-006476401050010 POUCH in 1 CARTON (64764-105-00) / 10 mL in 1 POUCH (64764-105-01)
64764-105-606476401056060 POUCH in 1 CARTON (64764-105-60) / 10 mL in 1 POUCH (64764-105-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/56f2023a-69b2-4470-b4ad-af7ec1be527a
  • NADAC price for package 64764010560

    GET /v1/drugs/nadac/64764010560

Use it

Look up 64764-105 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64764-105 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64764-105. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.